Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $424.82 | 14 | 93.3% |
| Education | $30.54 | 2 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $152.36 | 5 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $121.98 | 2 | $0 (2022) |
| PFIZER INC. | $64.21 | 3 | $0 (2023) |
| LEO Pharma Inc. | $43.66 | 1 | $0 (2022) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $42.16 | 3 | $0 (2022) |
| Mayne Pharma Inc. | $15.99 | 1 | $0 (2017) |
| PruGen, Inc. Pharmaceuticals | $15.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $30.54 | 2 | PFIZER INC. ($30.54) |
| 2022 | $289.76 | 10 | ABBVIE INC. ($152.36) |
| 2021 | $13.44 | 1 | Ortho Dermatologics, a division of Bausch Health US, LLC ($13.44) |
| 2017 | $121.62 | 3 | Novartis Pharmaceuticals Corporation ($90.63) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 01/23/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 08/26/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: IMMUNOLOGY | ||||||
| 06/08/2022 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Podiatry | ||||||
| 05/18/2022 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Podiatry | ||||||
| 05/12/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: IMMUNOLOGY | ||||||
| 03/26/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $43.66 | General |
| Category: DERMATOLOGY | ||||||
| 03/26/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: Inflammation & Immunology | ||||||
| 03/16/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: IMMUNOLOGY | ||||||
| 03/08/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $121.04 | General |
| Category: IMMUNOLOGY | ||||||
| 02/24/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Dermatology | ||||||
| 07/25/2017 | PruGen, Inc. Pharmaceuticals | — | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| 04/12/2017 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $90.63 | General |
| Category: DERMATOLOGY | ||||||
| 04/05/2017 | Mayne Pharma Inc. | DORYX (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,963 | 3,816 | $564,602 | $163,543 |
| 2022 | 12 | 2,138 | 4,182 | $601,293 | $172,293 |
| 2021 | 13 | 2,287 | 4,249 | $630,255 | $187,805 |
| 2020 | 13 | 2,162 | 4,114 | $541,738 | $143,821 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 230 | 270 | $75,060 | $27,136 | 36.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 224 | 259 | $75,369 | $22,204 | 29.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 380 | 454 | $108,432 | $21,733 | 20.0% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 100 | 128 | $56,183 | $16,092 | 28.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 319 | 1,930 | $52,110 | $10,860 | 20.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 112 | 112 | $31,136 | $9,738 | 31.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 59 | 59 | $25,016 | $7,508 | 30.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 88 | 93 | $33,073 | $7,244 | 21.9% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 18 | 20 | $9,180 | $3,026 | 33.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 61 | 63 | $7,182 | $2,585 | 36.0% |
| 99451 | Telephone or internet assessment and management service provided by consultative physician with written report, 5 minutes or more of medical consultative discussion and review | Office | 2021 | 45 | 45 | $4,365 | $1,331 | 30.5% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 11 | 12 | $1,194 | $603.37 | 50.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 609 | 720 | $136,080 | $41,854 | 30.8% |
| 17000 | Destruction of skin growth | Office | 2020 | 365 | 449 | $99,732 | $20,831 | 20.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 204 | 219 | $63,729 | $19,040 | 29.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 161 | 161 | $44,758 | $13,638 | 30.5% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 91 | 109 | $45,562 | $13,217 | 29.0% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 299 | 1,973 | $53,271 | $9,480 | 17.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 219 | 260 | $29,640 | $8,846 | 29.8% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 90 | 94 | $33,428 | $6,351 | 19.0% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2020 | 20 | 24 | $11,016 | $3,353 | 30.4% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 60 | 60 | $11,580 | $3,053 | 26.4% |
| 17282 | Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | Office | 2020 | 13 | 13 | $6,942 | $2,172 | 31.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 16 | $4,448 | $1,469 | 33.0% |
| 99451 | Telephone or internet assessment and management service provided by consultative physician with written report, 5 minutes or more of medical consultative discussion and review | Office | 2020 | 16 | 16 | $1,552 | $516.45 | 33.3% |
About Dr. Brian Kumasaka, MD
Dr. Brian Kumasaka, MD is a Dermatology healthcare provider based in Renton, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801971262.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Kumasaka, MD has received a total of $455.36 in payments from pharmaceutical and medical device companies, with $30.54 received in 2023. These payments were reported across 16 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($424.82).
As a Medicare-enrolled provider, Kumasaka has provided services to 8,550 Medicare beneficiaries, totaling 16,361 services with total Medicare billing of $667,463. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Renton, WA
- Active Since 10/26/2006
- Last Updated 11/14/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1801971262
Products in Payments
- SKYRIZI (Biological) $152.36
- COSENTYX (Biological) $121.98
- CIBINQO (Drug) $64.21
- ADBRY (Biological) $43.66
- JUBLIA (Drug) $28.72
- DORYX (Drug) $15.99
- DUOBRII (Drug) $13.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Renton
Dr. Marcus Tan, Md, Faad, Frcpc, MD, FAAD, FRCPC
Dermatology — Payments: $7,436
Dr. Jodie Sasaki, M.d., M.s, M.D., M.S
Dermatology — Payments: $5,741
Laura Walsh, Md, Phd, MD, PHD
Dermatology — Payments: $2,655
Zixiao Wang
Dermatology — Payments: $680.25
Dr. Craig Fujisaki, M.d, M.D
Dermatology — Payments: $615.06
Kevin Luk
Dermatology — Payments: $146.12